Zakerkish 2017.

Methods	Double‐blind, placebo‐controlled, parallel, 2‐arm RCT 6 weeks
Participants	Patients with diabetic peripheral neuropathy n = 134
Interventions	Duloxetine 30‐60 mg Placebo
Outcomes	Pain intensity 50% pain relief AEs
Notes	Unable to establish pain duration, unclear if chronic

AE: adverse event; BPI: Brief Pain Inventory; IASP: International Association for the Study of Pain; LANSS: Leeds Assessment of Neuropathic Symptoms and Signs; NRS: numeric rating scale; OA: osteoarthritis; PGIC: Patient Global Impression of Change; RCT: randomised controlled trial; VAS: visual analogue scale; WOMAC: Western Ontario and McMaster Universities Osteoarthritis pain scale